Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

2.9K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.9K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.4K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.4K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

674
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
674

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intersections of Autism and Sexual and Gender Diversity Among Young People in New Zealand.

Autism : the international journal of research and practice·2026
Same author

Huntington's Disease Human Lateral Ganglionic Eminence Precursors Differentiate into Functionally Mature Medium Spiny Neurons Exhibiting Pathology.

Stem cells (Dayton, Ohio)·2026
Same author

Cuprizone in Peanut Butter: An Alternative Method of Cuprizone Administration to Model Demyelination of the Central Nervous System.

Journal of the American Association for Laboratory Animal Science : JAALAS·2026
Same author

Genetic diagnostic outcomes from a 10-year research programme in autism in Aotearoa New Zealand.

Journal of the Royal Society of New Zealand·2025
Same author

Actuated Hydrogel Platforms To Study Brain Cell Behavior.

Advanced healthcare materials·2025
Same author

Oligodendrocytes in Huntington's Disease: A Review of Oligodendrocyte Pathology and Current Cell Reprogramming Approaches for Oligodendrocyte Modelling of Huntington's Disease.

Journal of neuroscience research·2024

Related Experiment Video

Updated: Dec 3, 2025

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies
12:13

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

7.5K

Cell Replacement Therapy for Huntington's Disease.

Ruth Monk1, Bronwen Connor2

  • 1Department of Pharmacology and Clinical Pharmacology, Centre for Brain Research, SMS, FMHS, University of Auckland, Auckland, New Zealand.

Advances in Experimental Medicine and Biology
|October 26, 2020
PubMed
Summary
This summary is machine-generated.

Huntington's disease (HD) is a genetic neurodegenerative disorder with no current treatments. Cell-based therapies offer a promising strategy to replace lost neurons and support brain function in HD patients.

More Related Videos

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy
11:22

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Published on: June 27, 2018

8.4K
Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
10:49

Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury

Published on: September 18, 2011

21.0K

Related Experiment Videos

Last Updated: Dec 3, 2025

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies
12:13

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

7.5K
Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy
11:22

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Published on: June 27, 2018

8.4K
Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
10:49

Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury

Published on: September 18, 2011

21.0K

Area of Science:

  • Neuroscience
  • Genetics
  • Regenerative Medicine

Background:

  • Huntington's disease (HD) is an inherited neurodegenerative disorder characterized by motor, cognitive, and psychiatric symptoms.
  • HD involves preferential degeneration of GABAergic medium spiny neurons (MSNs) in the striatum.
  • The disease is caused by a CAG repeat expansion leading to mutant Huntingtin protein (mHTT).

Purpose of the Study:

  • To explore cell-based therapies as a potential treatment strategy for Huntington's disease.
  • To discuss methods for restoring neuronal circuitry and function in HD.
  • To review various cell sources for potential HD therapeutic applications.

Main Methods:

  • Review of existing literature on cell-based therapies for neurodegenerative diseases.
  • Discussion of potential cell sources including fetal tissue, pluripotent stem cells, neural stem cells, and somatic cell reprogramming.
  • Analysis of the requirements for reconstituting striatal signaling networks in HD.

Main Results:

  • Cell-based therapies aim to replace degenerated neurons and provide neurotrophic support.
  • Successful therapy requires restoring the complex signaling network disrupted by MSN loss.
  • Various cell types are being investigated for their potential in HD treatment.

Conclusions:

  • Cell-based therapies represent a promising avenue for treating Huntington's disease.
  • Restoring MSN function and network integrity is crucial for therapeutic success.
  • Further research into fetal grafts, stem cells, and cell reprogramming is warranted for HD treatment development.